UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C.   20549
                     __________________________________

                                 FORM 10-QSB
                 Quarterly Report Under Section 13 or 15(d)
                   of the Securities Exchange Act of 1934.
                    ____________________________________


For the quarter ended April 30, 2002       Commission file number  000-26309


                         CORONADO EXPLORATIONS LTD.
           (Exact name of registrant as specified in its charter)

Delaware                                                           98-0200471
(State or other jurisdiction of                              (I.R.S. Employer
incorporation or organization)                            Identification No.)

6265 Stevenson Way
Las Vegas, Nevada, USA                                                  89120
(Address of principal executive offices)                           (zip code)


                Issuer's Telephone Number:    (702) 450-1600


     Indicate by check mark whether the registrant (1) has filed all  reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934  during  the  preceding 12 months (or for such shorter period  that  the
registrant  was required to file such reports), and (2) has been  subject  to
such filing requirements for the past 90 days.

                          Yes      X       No ____


     The  number of shares of Common Stock, $0.001 par value, outstanding  on
June 1, 2002, was 75,000,009 shares, held by approximately 40 stockholders.

<PAGE>

                         CORONADO EXPLORATIONS LTD.
                               APRIL 30, 2002
                                    INDEX

PART I - FINANCIAL INFORMATION                                        Page No.

Item 1.      Unaudited Financial Statements

             Condensed Balance Sheets                                      3

             Condensed Statement of Operations (Unaudited)                 4

             Condensed Statement of Stockholders' Deficit                  5

             Condensed Statements of Cash Flow (Unaudited)                 6

             Notes to Condensed Financial Statements                     7-8

Item 2.      Management's Discussion and Analysis of
               Financial Condition and Results of Operation                9

PART II - OTHER INFORMATION

Item 1.      Legal Proceedings                                            12

Item 2.      Changes in Securities                                        13

Item 3.      Defaults by the Company upon its Senior Securities           13

Item 4.      Submission of Matter to a Vote of Security Holders           13

Item 5.      Other Information                                            13

Item 6.      Exhibits and Reports on Form 8-K                          13-14

SIGNATURES                                                                15

<PAGE>
<TABLE>
PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

                         CORONADO EXPLORATIONS LTD.
                        (A Development Stage Company)
                          CONDENSED BALANCE SHEETS

                                                    April 30,     January 31,
                                                       2002           2002
                                                   (Unaudited)
<S>                                               <C>           <C>
Assets
Current Assets:
  Cash                                            $    26,485    $      4,831
  Prepaid expense                                       6,000             - -
                                                    ---------      ----------
   Total current assets                                32,485           4,831
                                                    ---------      ----------
Investment in and advances to Naturol Canada
Limited                                                   - -              31
                                                    ---------      ----------
                                                  $    32,485    $      4,862
                                                    =========      ==========
</TABLE>
<TABLE>
Liabilities and Shareholders' Deficit:
<S>                                              <C>             <C>
Current liabilities:
  Accounts payable                                $    56,186   $      62,038
  Note payable                                        102,229          26,565
  Due to Naturol (U.K.) Limited                         5,285             - -
  Due to Naturol Canada Limited                           - -              31
                                                    ---------      ----------
    Total current liabilities                         163,701          88,634
                                                    ---------      ----------
Investment in and advances to Naturol Canada
Limited                                                 9,567             - -
                                                    ---------      ----------
Shareholders' Deficit:
  Common stock 200,000,000 shares authorized par
value $.001, 75,000,009 shares issued and
outstanding at April 30, 2002 and January 31,
2002                                                   75,000          75,000
  Paid-in-capital                                      30,650          30,650
  Subscriptions receivable                           (28,400)        (28,400)
  Deficit accumulated during the developmental
stage                                               (218,033)       (161,022)
                                                    ---------      ----------
    Total shareholders' deficit                     (140,783)        (83,772)
                                                    ---------      ----------
    Total liabilities and shareholders' deficit   $    32,485   $       4,862
                                                    =========      ==========
</TABLE>
                 See notes to condensed financial statements
<PAGE>
<TABLE>
                         CORONADO EXPLORATIONS LTD.
                        (A Development Stage Company)
               CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)

                                                 Three Months          From
                                                    Ended         Inception
                                                  April 30,     June 18, 2001
                                                    2002              to
                                                                  April 30,
                                                                     2002
<S>                                          <C>              <C>
Professional fees                             $      39,237   $       136,835
License fees                                            - -            50,000
Interest expense                                        664               729
Equity in net loss of affiliate                      11,490            11,490
Office expense                                        5,620            18,979
                                                 -----------       -----------
Net loss                                       $      57,011   $       218,033
                                                 ===========       ===========
Net loss per share basic and diluted           $      (0.00)   $        (0.00)
                                                 ===========       ===========
Weighted average shares outstanding               75,000,009        53,277,495
                                                 ===========       ===========
</TABLE>
                 See notes to condensed financial statements
<PAGE>
<TABLE>
                         CORONADO EXPLORATIONS LTD.
                        (A Development Stage Company)
                CONDENSED STATEMENT OF STOCKHOLDERS' DEFICIT

                  Common Stock       Subscription    Paid In       Deficit
                 Shares      Amount    Receivable     Capital     Accumulated
                                                                  During The
                                                                Developmental
                                                                    Stage
<C>          <C>         <C>       <C>           <C>          <C>
Inception-
shares sold  48,400,000  $  48,400 $    (28,400) $        - - $           - -
Shares sold     335,000        335           - -       83,415             - -
Reverse
merger       26,265,009     26,265           - -     (52,765)             - -
Net loss            - -        - -           - -          - -       (161,022)
             ----------     ------    ----------     --------     -----------
Balance
January 31,
2002         75,000,009     75,000      (28,400)       30,650       (161,022)
Net loss            - -        - -           - -          - -        (57,011)
             ----------     ------    ----------     --------     -----------
Balance
April 30,
2002         75,000,009  $  75,000 $    (28,400) $     30,650 $     (218,033)
             ==========     ======    ==========     ========     ===========
</TABLE>
                 See notes to condensed financial statements

<PAGE>
<TABLE>
                         CORONADO EXPLORATIONS LTD.
                        (A Development Stage Company)
               CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)

                                                                       From
                                                    Three         Inception
                                                    Months      June 18, 2001
                                                    Ended             to
                                                  April 30,       April 30,
                                                     2002            2002
<S>                                            <C>            <C>
Cash flows from operating activities:
  Net loss                                     $   (57,011)   $     (218,033)
Changes in operating assets and liabilities:
  Prepaid expense                                    (6,000)           (6,000)
  Accounts payable                                   (5,852)            56,186
                                                   ---------       -----------
  Cash used in operating activities                 (68,863)         (167,847)
                                                   ---------       -----------
Cash flows from financing activities:
  Increase in note payable                            75,665            75,730
  Increase in due to Naturol (U.K.) Limited            5,285             5,285
  Proceeds from the sale of common stock                 - -           103,750
                                                   ---------       -----------
                                                      80,950           184,765
                                                   ---------       -----------
Cash flows from investing activities:
  Investment in and advances to Naturol Canada
Limited                                               9,567             9,567
                                                   ---------       -----------
Increase in cash                                     21,654            26,485

Cash beginning of period                              4,831               - -
                                                  ---------       -----------
Cash end of period                             $     26,485   $        26,485
                                                  =========       ===========
Supplemental disclosure of cash flow
information:
  Cash paid for interest                       $        - -   $           - -
                                                  =========       ===========
  Cash paid for income taxes                            - -               - -
                                                  =========       ===========
Noncash financing activities:
  Stock issued for subscription receivable     $        - -   $        28,400
                                                  =========       ===========
  Stock issued and note assumed in reverse
merger                                                  - -            52,765
                                                  =========       ===========
  Investment in affiliated company                      - -                31
                                                  =========       ===========
</TABLE>
                 See notes to condensed financial statements
<PAGE>

                         CORONADO EXPLORATIONS LTD.
                        (A Development Stage Company)
                   NOTES TO CONDENSED FINANCIAL STATEMENTS

Note 1 - Basis of Presentation

     The unaudited condensed financial statements have been prepared in
accordance with United States generally accepted accounting principles for
interim financial information and with the instructions to Form 10-QSB and
reflect all adjustments which, in the opinion of management, are necessary
for a fair presentation.  All such adjustments are of a normal recurring
nature.  The results of operations for the interim period are not necessarily
indicative of the results to be expected for a full year.  Certain amounts in
the prior year statements have been reclassified to conform to the current
year presentations.  The statements should be read in conjunction with the
financial statements and footnotes thereto included in the Company's Form 10-
KSB for the year ended January 31, 2002.

Note 2 - Commitments and Contingencies

Going Concern
     The accompanying condensed financial statements have been prepared
assuming that the Company will continue as a going concern.  The ability of
the Company to continue as a going concern is dependent upon management's
ability to attain profitable operations based on the development of products
that can be sold.  Management intends to use borrowings and security sales to
mitigate the affects of its cash position, however no assurance can be given
that debt or equity financing, if and when required, will be available.  The
financial statements do not include any adjustments relating to the
recoverability and classification of recorded assets and classification of
liabilities that might be necessary should the Company be unable to continue
in existence.

Note 3 - Note Payable

     The Company in the quarter ended April 30, 2002 borrowed $75,000 from a
shareholder.  The demand note has an interest rate of 10%.  Total borrowed,
including unpaid interest, at April 30, 2002 was $102,229.

Note 4 - Due to Affiliate

     The Company borrowed $4,285 from Naturol (U.K.) Limited. The interest
rate on the demand note is 10%.

Note 5 - Marketing Agreement

     The Company entered into a media and public relations consulting
agreement for a term of one year requiring a $6,000 per month consulting fee
commencing on April 1, 2002.  The first payment included $6,000 for the final
month of the agreement.  This has been recorded as a prepaid expense and will
be expensed in March, 2003.

<PAGE>

                         CORONADO EXPLORATIONS LTD.
                        (A Development Stage Company)
                   NOTES TO CONDENSED FINANCIAL STATEMENTS

Note 6 - Investment in Naturol Canada Limited

     An investment in Naturol Canada Limited is accounted for under the
equity method as the Company owns 49% of the outstanding stock.  During the
quarter, the Company advanced $1,892 to Naturol Canada Limited and recorded a
$11,490 loss on the investment which represented the Company's percentage
ownership of the total loss.

<PAGE>

Item 2.   Management's Discussion and Analysis of Financial Condition and
          Results of Operations.

    This  report  contains forward-looking statements.   Actual  results  and
events  could  differ  materially  from  those  projected,  anticipated,   or
implicit,  in the forward-looking statements as a result of the risk  factors
set forth below and elsewhere in this report.

   With the execution of historical matters, the matters discussed herein are
forward-looking  statements that involve risks and  uncertainties.   Forward-
looking  statements  include, but are not limited to,  statements  concerning
anticipated  trends in revenues and net income, the date of  introduction  or
completion  of our products, projections concerning operations and  available
cash  flow.   Our  actual results could differ materially  from  the  results
discussed  in  such forward-looking statements primarily  as  the  result  of
insufficient cash to pursue production and marketing efforts.  The  following
discussion  of  our financial condition and results of operations  should  be
read  in  conjunction  with our financial statements and  the  related  notes
thereto appearing elsewhere herein.

Overview

     On  January 17, 2002, the Company completed a reverse triangular  merger
between Coronado Subsidiary Corp. ("CSC"), a Nevada corporation and a  wholly
owned  subsidiary  of  Coronado,  and  Naturol  Inc.,  A  Nevada  corporation
("Naturol"), whereby Coronado issued 50,000,009 shares of its 144  restricted
common  stock  in  exchange for 100% of Naturol's outstanding  common  stock.
Pursuant  to  the  terms of the merger, Naturol merged with CSC  wherein  CSC
ceased  to  exist and Naturol became a wholly owned subsidiary  of  Coronado.
Prior  to  the  Merger,  Coronado was engaged in the exploration  of  mineral
properties  and  subsequently  became a shell corporation.  All  business  of
Coronado  is  now  conducted  through its wholly owned  subsidiary,  Naturol.
Naturol owns the exclusive North American License for extraction technologies
employed  in the flavors, fragrances and pharmaceutical industries.  Coronado
is  a  development  stage company, has no revenues to  date  and  has  raised
capital for initial development through the issuance of its securities.

     The  financial statements presented are of Naturol for the three  months
ending  April  30, 2002. These financial statements are for the three  months
ending April 30, 2002 to conform with Coronado's reporting the quarter ending
April  30,  2002. As a result of the recent merger and the insignificance  of
Coronado's financial information as a shell corporation, the presentation  of
financial information is of Naturol from inception.

Plan of Operation

     Since  our operations have been solely based on Naturol's business since
Naturol became a wholly owned subsidiary of Coronado on January 17, 2002, our
plan  of  operation  has assumed the plan of operation of Naturol.  Naturol's
business  is  to  eventually provide a service of  extraction  employing  the
proprietary Naturol Extraction Technology.

     We  plan on satisfying our cash obligations over the next twelve  months
through  additional equity and/or third party financing. We do not anticipate
generating  revenues  sufficient  enough  to  satisfy  our  working   capital
requirements within the next twelve months.

<PAGE>

     Commercialization of Naturol Extraction Technology is a function,  to  a
large  extent,  of  the  efforts of the benefits of  the  extraction  program
launched in March 2002 at the Prince Edward Island Food Technology Center. As
a  consequence  of the progress of the Prince Edward Island  Food  Technology
Centre's  development efforts, we believe Coronado will be in a  position  to
commence  the commercialization of the extraction of saw palmetto and  lutein
for  dietary supplements in the Nutraceutical industries which may result  in
revenues in 2002. Additionally, we believe the extraction of taxanes for  the
pharmaceutical  industries may result in revenues in 2003.  Other  extraction
technical  efforts  which  may result in revenues in  the  next  three  years
includes  extraction  for  the  fixed oils industry,  extraction  of  certain
biomasses for food companies, and the extraction of natural astaxanthin as an
antioxident for nutraceutical applications and as a natural colorant.

     We  anticipate the need for approximately 2.5 million dollars  over  the
next  twelve  (12)  months  to  be utilized for  general  and  administrative
expenses,  compensation to the Naturol Management team for  services  to  the
Company,  patent expenses, clinical, animal and toxicology testing  necessary
to  gain FDA acceptance of the use of Naturol extraction solvents as  a  food
contacting material, payment obligations under the National Research Council.

     As  a  result of our agreement between Naturol (Canada) Limited and  the
National Research Council Canada, research and development is being conducted
with  the Prince Edward Island Food Technology Center based in Charlottetown,
Prince  Edward Island, Canada at a total cost of approximately  $326,600,  of
which  Naturol  (Canada)  Limited is obligated to pay  $109,300.  The  Prince
Edward  Island  Food  Technology  Center is a  provincially  funded  facility
providing  a  range  of  services  to the agri-food  and  seafood  processing
industries.  Its  resources include project management, laboratory  analysis,
technical   support,   applications  development   and   biomass   extraction
technology.   During this research period we plan on being able to  establish
the  Naturol Extraction Technology as a means of servicing various  companies
in  the  extraction  of  compounds on a commercial toll  processing  facility
basis.  In other words, we plan on generating revenues by charging a  fee  to
companies for the utilization of our Naturol Extraction Technology.

     As  a result of our License Agreement with MGA Holdings, Inc., (formerly
Naturol  Limited  (Jersey)), we are obligated to pay  a  minimum  payment  of
$360,000 per year, paid quarterly, of which we have paid $50,000 in the  last
quarter.  We  have received a written confirmation that the failure  to  make
timely payments under the License Agreement does not constitute a default  in
the License Agreement.

     We anticipate the purchase of several pieces of equipment and the hiring
of  technical  personnel necessary for the scale up and commercialization  of
the  Naturol Technology.  Purchase of these items are required now  in  order
for  Naturol  to  proceed expeditiously with its business  plan  to  generate
income  in  the later part of 2002 or early 2003. Our ability to  proceed  as
planned  is  limited by the availability of funds.  However, once efforts  to
raise  the  anticipated $2.5 million funding is complete we will be  able  to
proceed rapidly toward commercialization of the Naturol Technology.

We  are  currently utilizing the facilities of the Prince Edward Island  Food
Technology Center under Naturol (Canada) Limited's contract with the National
Research  Council Canada, which supplies us with the personnel and  equipment
for research and development. Our officers have been working without pay on a
part  time  basis  until  such time as sufficient  capital  is  available  to
commence  the  payment  of  salaries. Upon securing  sufficient  funding,  we
anticipate the hiring of several management, technical and support  personnel
necessary for the expeditious governmental approval and commercialization  of
the  Naturol technology.  We also will commence the compensate of our  senior
management for their ongoing efforts on behalf of the company.

<PAGRE>

Liquidity and Capital Resources

     A  critical  component  of  our operating plan impacting  our  continued
existence  is  the  ability to obtain additional capital  through  additional
equity  and/or debt financing.  We do not anticipate enough positive internal
operating  cash flow until such time as we can generate substantial  revenues
from fees earned as a result of our Naturol Extraction Technology, which  may
take the next few years to fully realize.  In the event we cannot obtain  the
necessary  capital  to pursue our strategic plan, we may  have  to  cease  or
significantly  curtail  our  operations.  This would  materially  impact  our
ability to continue operations.

     Our near term cash requirements are anticipated to be offset through the
receipt  of funds from private placement offerings and loans obtained through
private  sources.   Since inception, we have financed cash flow  requirements
through  debt  financing and issuance of common stock for cash and  services.
As  we  expand  operational  activities, we may continue  to  experience  net
negative  cash  flows  from  operations,  pending  receipt  of  servicing  or
licensing fees, and will be required to obtain additional financing  to  fund
operations  through common stock offerings and bank borrowings to the  extent
necessary to provide working capital.

     Over  the  next  twelve  months we believe  that  existing  capital  and
anticipated  funds  from  operations  will  not  be  sufficient  to   sustain
operations and planned expansion.  Consequently, we will be required to  seek
additional  capital  in  the  future to fund  growth  and  expansion  through
additional  equity or debt financing or credit facilities.  No assurance  can
be  made that such financing would be available, and if available it may take
either the form of debt or equity.  In either case, the financing could  have
a negative impact on our financial condition and our Stockholders.

We  anticipate incurring operating losses over the next twelve  months.   Our
lack  of  operating  history makes predictions of  future  operating  results
difficult  to  ascertain.  Our prospects must be considered in light  of  the
risks, expenses and difficulties frequently encountered by companies in their
early  stage  of  development,  particularly companies  in  new  and  rapidly
evolving  markets such as technology related companies.  Such risks  include,
but  are not limited to, an evolving and unpredictable business model and the
management  of  growth.  To address these risks we must, among other  things,
obtain  a customer base, implement and successfully execute our business  and
marketing  strategy, continue to develop and upgrade technology and products,
provide  superior extraction results, file patent applications to  cover  new
processing technology and new compositions discovered during our research and
development efforts, conduct tests in support of, and file with FDA  for  use
of  Naturol  solvents  as food contacting materials, respond  to  competitive
developments,,  and attract, retain and motivate qualified personnel.   There
can  be no assurance that we will be successful in addressing such risks, and
the  failure  to  do so can have a material adverse effect  on  our  business
prospects, financial condition and results of operations.

     As of April 30, 2002, the Company had assets of $32,485, and $163,701 of
current  liabilities.  The current liabilities include  accounts  payable  of
$56,186, notes payable of $107,514.

<PAGE>

Going Concern

     The  Company's auditors have requested the Company provide Note 2 in the
Company's financial statement as follows:

     "The accompanying condensed financial statements have been prepared
assuming that the Company will continue as a going concern.  The ability of
the Company to continue as a going concern is dependent upon management's
ability to attain profitable operations based on the development of products
that can be sold.  Management intends to use borrowings and security sales to
mitigate the affects of its cash position, however no assurance can be given
that debt or equity financing, if and when required, will be available.  The
financial statements do not include any adjustments relating to the
recoverability and classification of recorded assets and classification of
liabilities that might be necessary should the Company be unable to continue
in existence."

Material Risks

     We  are  a  development  stage company, recently  reorganized  and  have
minimal  operating  history,  which  makes  an  evaluation  of  us  extremely
difficult. At this stage of our business operations, even with our good faith
efforts,  potential  investors  have  a  high  probability  of  losing  their
investment.

     As  a  result  of  our  recent reorganization we have  yet  to  generate
revenues  from operations and have been focused on organizational,  start-up,
market  analysis and fund raising activities since we incorporated.  Although
we  have a project to market, there is nothing at this time on which to  base
an  assumption  that our business operations will prove to be  successful  or
that we will ever be able to operate profitably. Our future operating results
will  depend on many factors, including our ability to raise adequate working
capital,  demand and acceptance of our project, the level of our  competition
and our ability to attract and maintain key management and employees.

     While  Management  believes its estimates of projected  occurrences  and
events  are  within  the  timetable of its business plan,  there  can  be  no
guarantees or assurances that the results anticipated will occur.

     As  a result of our deficiency in working capital and other factors, the
auditors, as well as the Naturol management, are concerned about the  ability
of the company to continue as a going concern without adequate cash infusion.
Therefore,  we  have  proceeded with aggressive efforts  to  seek  and  raise
funding  through  equity private placements, debt facilities  and  government
grants.   The  Naturol  management believes it will be  successful  in  those
efforts.

PART II--OTHER INFORMATION

Item 1.        Legal Proceedings.

None

Item 2.        Changes in Securities.

None

<PAGE>

Item 3.        Defaults by the Company upon its Senior Securities.

None.

Item 4.        Submission of Matter to a Vote of Security Holders.

None

Item 5.         Other Information.

None

Item 6.        Exhibits and Reports on Form 8-K.
(a)  Exhibits
2(a)**         Agreement and Plan of Merger between Coronado Explorations Ltd
               and Naturol, Inc.
2(b)***        Amendment  No.  1 to the Agreement and Plan of Merger  between
               Coronado Explorations Ltd and Naturol, Inc.
3(i)(a)*       Certificate   of   Incorporation  of   Coronado   Explorations
               Ltd.-Dated February 2, 1999
3(i)(b)*       Amended  and  Restated Articles of Incorporation  of  Coronado
               Explorations Ltd.-Dated May 10, 1999
3(i)(c)****    Certificate  of  Amendment of Certificate of Incorporation  of
               Coronado Explorations Ltd.-filed October 5, 2000
3(i)(d)****    Articles of Incorporation of Naturol, Inc.-Dated June 9, 2001
3(ii)(e)*      Bylaws of Coronado Explorations Ltd.-Dated February 2, 1999
3(ii)(f)****   Bylaws of Naturol, Inc.-Dated August 20, 2001
3(i)(g)***     Certificate  of Merger between Coronado Subsidiary  Corp.  and
               Naturol, Inc.
10(a)***       License  Agreement between Naturol, Inc., a Nevada corporation
               and Naturol Limited, a corporation incorporated under the laws
               of Jersey.
10(b)****      Agreement between National Research Council Canada and Naturol
               (Canada) Limited-Dated October 23, 2001
10(c)          Media/  Public  Relations  Agreement  with  Jack  Wynn  (filed
               herewith)
99***          Press Release - Dated January 22, 2002
99***          Press Release - Dated January 23, 2002
99****         Press Release - Dated January 23, 2002
99****         Press Release - Dated January 29, 2002
99****         Press Release - Dated February 5, 2002
99****         Press Release - Dated February 12, 2002
99****         Press Release - Dated March 4, 2002
99*****        Press Release - Dated June 5, 2002
______
*              Filed in form 10SB12G on June 9, 1999
**             Filed in form 8-K on October 25, 2001
***            Filed in form 8-K on January 25, 2002
****           Filed in form 10-KSB on April 30, 2002
*****          Filed in form 8-K on June 12, 2002
(b.) Reports on Form 8-K
1.   8-K Report filed on April 26, 2002, Change of Accountants to Weaver &
     Martin, LLC.

<PAGE>

                                 SIGNATURES

     Pursuant  to  the requirements of Section 13 or 15(d) of the  Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.

                              CORONADO EXPLORATIONS, LTD.

                              By:/s/ Paul McClory
                                Paul McClory, President/Director

                                Dated:  June 13, 2002

     Pursuant  to  the requirements of the Securities Exchange Act  of  1934,
this  report has been signed below by the following persons on behalf of  the
registrant and in the capacities and on the dates indicated.

NAME                         OFFICE                             DATE

/s/ Isaac Moss                Secretary/Treasurer/             June 13, 2002
Isaac Moss                    Director


/s/ Paul McClory              President/Director               June 13, 2002
Paul McClory


/s/ Michael Davenhill         Chief Financial Officer/         June 13, 2002
Michael Davenhill             Director


/s/ Michael Ram               Director                         June 13, 2002
Michael J. Ram